A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

Clinical trial NCT07535112 · RECRUITING

Trial details

NCT number: NCT07535112
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced/Metastatic Colorectal Adenocarcinoma

Start date: 2026-04-07
Primary completion: 2029-07-27
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.